Form 8-K - Current report:
SEC Accession No. 0001654954-25-005135
Filing Date
2025-05-06
Accepted
2025-05-06 13:58:12
Documents
16
Period of Report
2025-05-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K canna_8k.htm   iXBRL 8-K 25684
2 EX-99.1 canna_ex991.htm EX-99.1 4954
  Complete submission text file 0001654954-25-005135.txt   149473

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA canna-20250506.xsd EX-101.SCH 5882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE canna-20250506_lab.xml EX-101.LAB 13593
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE canna-20250506_cal.xml EX-101.CAL 901
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE canna-20250506_pre.xml EX-101.PRE 8557
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE canna-20250506_def.xml EX-101.DEF 2102
19 EXTRACTED XBRL INSTANCE DOCUMENT canna_8k_htm.xml XML 3669
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

EIN.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27055 | Film No.: 25916544
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)